Related Experiment Video
Updated: Aug 21, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Diagnostic utility of neuropsychological performance and quantitative MRI-based measurement in Alzheimer disease
Huali Wang1, Liang Shu, Jingxia Xie
1Department of Geriatric Psychiatry, Peking University Institute of Mental Health, Peking University Third Hospital, Beijing, China. hualiwang@yahoo.com
Abstract:
This study was designed to examine the roles of the characteristic cognitive indicators and specific MRI-based measurements in the differential diagnoses of Alzheimer disease (AD), vascular dementia (VaD), and normal aging. Fifty-two probable AD patients were recruited for the study. Twenty-seven VaD patients and 35 age-matched normal older adults (NC) were included as controls. All subjects underwent a battery of standardized neuropsychological tests. The MRI-based quantification technique was used to measure the volumes and T2 relaxation time (T2) of medial temporal lobe structures. Stepwise discriminant analyses showed cognitive indicators had a sensitivity ranging from 82% to 100% and specificity from 82% to 97% for differentiating AD from non-AD cases (VaD and normal controls), and the quantitative MRI-based measurements of medial temporal lobe structures correctly classified AD cases from non-AD cases with sensitivity from 80% to 96% and specificity from 83% to 97%. ROC curve analyses showed that the combination of cognitive and MRI measurements slightly increased the diagnostic accuracy of AD. The results suggest that both cognitive indicators and MRI-based medial temporal lobe measurements may be useful in differentiating AD from VaD and normal older adults. The combination of these possible indicators is promising in the early diagnosis of AD.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021